Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| Allakos Inc.ALLK · Entity 79644 | member - potential 10% group | March 09, 2021 | March 11, 2021 |
| TIVITY HEALTH, INC.TVTY · Entity 125776 | Director | August 24, 2020 | August 25, 2020 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
Allakos Inc.
Report date March 09, 2021 · Filed March 11, 2021
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | IndirectBy Hudson Capital LLC | 31,054 |
Reported balance
After 2021-03-09 transaction · row 2
Account identity is unresolved; indirect or unspecified ownership is not merged.
1 source rowRow 2 · 2021-03-09 · Sale · Disposed 1,500 · Balance 31,054 F3: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $124.10 - $125.04, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote to this Form 4. F4: Shares held prior to the reported transaction consisted of an aggregate of 32,554 shares received in pro rata distributions from APNG I subsequent to the Reporting Person's most recent Section 16 report, which distribution was not required to be reported pursuant to Section 16. F5: These shares are owned by Hudson Capital, LLC, a limited liability company of which the Reporting Person is the managing member. The Reporting Person disclaims beneficial ownership of such shares, except to the extent of his pecuniary interest therein |
| Common StockSEC Table I · non-derivative | IndirectBy Hudson Capital LLC | 30,354 |
Reported balance
After 2021-03-09 transaction · row 3
Account identity is unresolved; indirect or unspecified ownership is not merged.
1 source rowRow 3 · 2021-03-09 · Sale · Disposed 700 · Balance 30,354 F6: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $125.515 - $125.80, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote to this Form 4. F5: These shares are owned by Hudson Capital, LLC, a limited liability company of which the Reporting Person is the managing member. The Reporting Person disclaims beneficial ownership of such shares, except to the extent of his pecuniary interest therein |
| Common StockSEC Table I · non-derivative | IndirectBy Hudson Capital LLC | 28,247 |
Reported balance
After 2021-03-10 transaction · row 4
Account identity is unresolved; indirect or unspecified ownership is not merged.
1 source rowRow 4 · 2021-03-10 · Sale · Disposed 2,107 · Balance 28,247 F7: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $124.00 - $124.86, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote to this Form 4. F5: These shares are owned by Hudson Capital, LLC, a limited liability company of which the Reporting Person is the managing member. The Reporting Person disclaims beneficial ownership of such shares, except to the extent of his pecuniary interest therein |
| Common StockSEC Table I · non-derivative | IndirectBy Hudson Capital LLC | 18,220 |
Reported balance
After 2021-03-11 transaction · row 5
Account identity is unresolved; indirect or unspecified ownership is not merged.
1 source rowRow 5 · 2021-03-11 · Sale · Disposed 10,027 · Balance 18,220 F8: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $123.00 - $123.99, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote to this Form 4. F5: These shares are owned by Hudson Capital, LLC, a limited liability company of which the Reporting Person is the managing member. The Reporting Person disclaims beneficial ownership of such shares, except to the extent of his pecuniary interest therein |
| Common StockSEC Table I · non-derivative | IndirectBy Hudson Capital LLC | 8,972 |
Reported balance
After 2021-03-11 transaction · row 6
Account identity is unresolved; indirect or unspecified ownership is not merged.
1 source rowRow 6 · 2021-03-11 · Sale · Disposed 9,248 · Balance 8,972 F9: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $124.00 - $124.89, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote to this Form 4. F5: These shares are owned by Hudson Capital, LLC, a limited liability company of which the Reporting Person is the managing member. The Reporting Person disclaims beneficial ownership of such shares, except to the extent of his pecuniary interest therein |
| Common StockSEC Table I · non-derivative | IndirectBy Hudson Capital LLC | 8,000 |
Reported balance
After 2021-03-11 transaction · row 7
Account identity is unresolved; indirect or unspecified ownership is not merged.
1 source rowRow 7 · 2021-03-11 · Sale · Disposed 972 · Balance 8,000 F10: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $125.02 - $125.50, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote to this Form 4. F5: These shares are owned by Hudson Capital, LLC, a limited liability company of which the Reporting Person is the managing member. The Reporting Person disclaims beneficial ownership of such shares, except to the extent of his pecuniary interest therein |
| Common StockSEC Table I · non-derivative | IndirectSee Footnote | 2,071,147 |
Reported balance
Holding disclosure · report date 2021-03-09 · row 1
Holding and transaction disclosures are not merged.
1 source rowRow 1 · Balance 2,071,147 F1: Reflects a distribution in kind effected by Alta Partners NextGen Fund I L.P. ("APNG I") subsequent to the Reporting Person's most recent Section 16 report, which distribution was not required to be reported pursuant to Section 16. F2: These shares are directly held by APNG I. Alta Partners NextGen Fund I Management, LLC ("APNG I Management") is the general partner of APNG I. The Reporting Person is one of three managing directors of APNG I Management and, as such, has voting and investment control with respect to the shares held by APNG I. The Reporting Person disclaims beneficial ownership of all shares held by APNG I, except to the extent of his pecuniary interest therein. |
Filing footnotes · ownership attribution and instrument terms
F1: Reflects a distribution in kind effected by Alta Partners NextGen Fund I L.P. ("APNG I") subsequent to the Reporting Person's most recent Section 16 report, which distribution was not required to be reported pursuant to Section 16.
F2: These shares are directly held by APNG I. Alta Partners NextGen Fund I Management, LLC ("APNG I Management") is the general partner of APNG I. The Reporting Person is one of three managing directors of APNG I Management and, as such, has voting and investment control with respect to the shares held by APNG I. The Reporting Person disclaims beneficial ownership of all shares held by APNG I, except to the extent of his pecuniary interest therein.
F3: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $124.10 - $125.04, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote to this Form 4.
F4: Shares held prior to the reported transaction consisted of an aggregate of 32,554 shares received in pro rata distributions from APNG I subsequent to the Reporting Person's most recent Section 16 report, which distribution was not required to be reported pursuant to Section 16.
F5: These shares are owned by Hudson Capital, LLC, a limited liability company of which the Reporting Person is the managing member. The Reporting Person disclaims beneficial ownership of such shares, except to the extent of his pecuniary interest therein
F6: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $125.515 - $125.80, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote to this Form 4.
F7: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $124.00 - $124.86, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote to this Form 4.
F8: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $123.00 - $123.99, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote to this Form 4.
F9: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $124.00 - $124.89, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote to this Form 4.
F10: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $125.02 - $125.50, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote to this Form 4.
TIVITY HEALTH, INC.
Report date August 24, 2020 · Filed August 25, 2020
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 76,211 |
Reported balance
After 2020-08-24 transaction · row 1
1 source rowRow 1 · 2020-08-24 · Grant · Acquired 1,821 · Balance 76,211 F1: Reflects restricted stock units that vest in full on August 24, 2021. |
Filing footnotes · ownership attribution and instrument terms
F1: Reflects restricted stock units that vest in full on August 24, 2021.
Past disclosures · reporting ended (1)
No longer tracked through insider filings. These historical balances do not imply present ownership or a zero position.
Tyra Biosciences, Inc.
Report date September 17, 2021 · Filed September 17, 2021
Jointly reported with Alta Partners NextGen Fund II Management, LLC, Alta Partners NextGen Fund II, L.P., JANNEY DANIEL
Section 16 reporting ended · disclosed 2021-09-17. Current position is not established by this disclosure.
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | IndirectSee footnote | 4,080,296 |
Last balance in matching sequence
After 2021-09-17 transaction · row 2
Source-order balances reconcile. Account continuity and personal attribution are not independently verified.
2 source rowsRow 1 · 2021-09-17 · Conversion · Acquired 3,811,117 · Balance 3,924,046 F1: On September 17, 2021, each share of Series A Preferred Stock and each share of Series B Preferred Stock converted into Common Stock of the Issuer at a ratio of 1-for-2.5974 without payment of further consideration upon closing of the initial public offering of the Issuer's common stock. The shares had no expiration date. As a result of the Issuer's initial public offering, the reporting persons are no longer 10% owners of the Issuer's common stock and are, therefore, no longer subject to Section 16 in connection with their transactions in the equity securities of the Issuer. F2: These securities are held directly by Alta Partners NextGen Fund II, L.P. (the "APNG II"). The shares directly held by APNG II are indirectly held by Alta Partners NextGen Fund II Management, LLC ("APNG II Management"), which is the general partner of APNG II. The individual managing directors of APNG II Management are Robert More, Peter Hudson and Daniel Janney. The managing directors of APNG II Management exercise shared voting and investment control with respect to the shares held by APNG II. APNG II Management, Mr. Hudson and Mr. Janney disclaim beneficial ownership of all shares held by APNG II, except to the extent of its or their respective pecuniary interests therein. Mr. More is a director of the Issuer and files separate Section 16 reports. Row 2 · 2021-09-17 · Purchase · Acquired 156,250 · Balance 4,080,296 F2: These securities are held directly by Alta Partners NextGen Fund II, L.P. (the "APNG II"). The shares directly held by APNG II are indirectly held by Alta Partners NextGen Fund II Management, LLC ("APNG II Management"), which is the general partner of APNG II. The individual managing directors of APNG II Management are Robert More, Peter Hudson and Daniel Janney. The managing directors of APNG II Management exercise shared voting and investment control with respect to the shares held by APNG II. APNG II Management, Mr. Hudson and Mr. Janney disclaim beneficial ownership of all shares held by APNG II, except to the extent of its or their respective pecuniary interests therein. Mr. More is a director of the Issuer and files separate Section 16 reports. |
| Series A Preferred StockSEC Table II · derivative / convertible security | IndirectSee footnote | 0 |
Reported balance
After 2021-09-17 transaction · row 3
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 3 · 2021-09-17 · Conversion · Disposed 1,212,122 · Balance 0 F1: On September 17, 2021, each share of Series A Preferred Stock and each share of Series B Preferred Stock converted into Common Stock of the Issuer at a ratio of 1-for-2.5974 without payment of further consideration upon closing of the initial public offering of the Issuer's common stock. The shares had no expiration date. As a result of the Issuer's initial public offering, the reporting persons are no longer 10% owners of the Issuer's common stock and are, therefore, no longer subject to Section 16 in connection with their transactions in the equity securities of the Issuer. F2: These securities are held directly by Alta Partners NextGen Fund II, L.P. (the "APNG II"). The shares directly held by APNG II are indirectly held by Alta Partners NextGen Fund II Management, LLC ("APNG II Management"), which is the general partner of APNG II. The individual managing directors of APNG II Management are Robert More, Peter Hudson and Daniel Janney. The managing directors of APNG II Management exercise shared voting and investment control with respect to the shares held by APNG II. APNG II Management, Mr. Hudson and Mr. Janney disclaim beneficial ownership of all shares held by APNG II, except to the extent of its or their respective pecuniary interests therein. Mr. More is a director of the Issuer and files separate Section 16 reports. |
| Series B Preferred StockSEC Table II · derivative / convertible security | IndirectSee footnote | 0 |
Reported balance
After 2021-09-17 transaction · row 4
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 4 · 2021-09-17 · Conversion · Disposed 255,160 · Balance 0 F1: On September 17, 2021, each share of Series A Preferred Stock and each share of Series B Preferred Stock converted into Common Stock of the Issuer at a ratio of 1-for-2.5974 without payment of further consideration upon closing of the initial public offering of the Issuer's common stock. The shares had no expiration date. As a result of the Issuer's initial public offering, the reporting persons are no longer 10% owners of the Issuer's common stock and are, therefore, no longer subject to Section 16 in connection with their transactions in the equity securities of the Issuer. F2: These securities are held directly by Alta Partners NextGen Fund II, L.P. (the "APNG II"). The shares directly held by APNG II are indirectly held by Alta Partners NextGen Fund II Management, LLC ("APNG II Management"), which is the general partner of APNG II. The individual managing directors of APNG II Management are Robert More, Peter Hudson and Daniel Janney. The managing directors of APNG II Management exercise shared voting and investment control with respect to the shares held by APNG II. APNG II Management, Mr. Hudson and Mr. Janney disclaim beneficial ownership of all shares held by APNG II, except to the extent of its or their respective pecuniary interests therein. Mr. More is a director of the Issuer and files separate Section 16 reports. |
Filing footnotes · ownership attribution and instrument terms
F1: On September 17, 2021, each share of Series A Preferred Stock and each share of Series B Preferred Stock converted into Common Stock of the Issuer at a ratio of 1-for-2.5974 without payment of further consideration upon closing of the initial public offering of the Issuer's common stock. The shares had no expiration date. As a result of the Issuer's initial public offering, the reporting persons are no longer 10% owners of the Issuer's common stock and are, therefore, no longer subject to Section 16 in connection with their transactions in the equity securities of the Issuer.
F2: These securities are held directly by Alta Partners NextGen Fund II, L.P. (the "APNG II"). The shares directly held by APNG II are indirectly held by Alta Partners NextGen Fund II Management, LLC ("APNG II Management"), which is the general partner of APNG II. The individual managing directors of APNG II Management are Robert More, Peter Hudson and Daniel Janney. The managing directors of APNG II Management exercise shared voting and investment control with respect to the shares held by APNG II. APNG II Management, Mr. Hudson and Mr. Janney disclaim beneficial ownership of all shares held by APNG II, except to the extent of its or their respective pecuniary interests therein. Mr. More is a director of the Issuer and files separate Section 16 reports.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| September 17, 2021 Filed Sep 17, 2021 20:47 UTC | Tyra Biosciences, Inc. TYRA · Entity 4680 | ConversionSeries B Preferred Stock · Derivative | 255,160 | $0.00 | $0.00 |
DisclosureSEC source: 0000899243-21-036429 · doc4.xml · derivative · entry 4 Alta Partners NextGen Fund II Management, LLC · CIK 0001881002 · 10% owner Alta Partners NextGen Fund II, L.P. · CIK 0001768658 · 10% owner Hudson Peter A · CIK 0001674884 · 10% owner JANNEY DANIEL · CIK 0001198325 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · See footnote Disclosed balance after: 0 Underlying: Common Stock · 662,752 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: On September 17, 2021, each share of Series A Preferred Stock and each share of Series B Preferred Stock converted into Common Stock of the Issuer at a ratio of 1-for-2.5974 without payment of further consideration upon closing of the initial public offering of the Issuer's common stock. The shares had no expiration date. As a result of the Issuer's initial public offering, the reporting persons are no longer 10% owners of the Issuer's common stock and are, therefore, no longer subject to Section 16 in connection with their transactions in the equity securities of the Issuer. F1 · derivative.exercise_date: On September 17, 2021, each share of Series A Preferred Stock and each share of Series B Preferred Stock converted into Common Stock of the Issuer at a ratio of 1-for-2.5974 without payment of further consideration upon closing of the initial public offering of the Issuer's common stock. The shares had no expiration date. As a result of the Issuer's initial public offering, the reporting persons are no longer 10% owners of the Issuer's common stock and are, therefore, no longer subject to Section 16 in connection with their transactions in the equity securities of the Issuer. F1 · derivative.expiration_date: On September 17, 2021, each share of Series A Preferred Stock and each share of Series B Preferred Stock converted into Common Stock of the Issuer at a ratio of 1-for-2.5974 without payment of further consideration upon closing of the initial public offering of the Issuer's common stock. The shares had no expiration date. As a result of the Issuer's initial public offering, the reporting persons are no longer 10% owners of the Issuer's common stock and are, therefore, no longer subject to Section 16 in connection with their transactions in the equity securities of the Issuer. F2 · ownership.nature: These securities are held directly by Alta Partners NextGen Fund II, L.P. (the "APNG II"). The shares directly held by APNG II are indirectly held by Alta Partners NextGen Fund II Management, LLC ("APNG II Management"), which is the general partner of APNG II. The individual managing directors of APNG II Management are Robert More, Peter Hudson and Daniel Janney. The managing directors of APNG II Management exercise shared voting and investment control with respect to the shares held by APNG II. APNG II Management, Mr. Hudson and Mr. Janney disclaim beneficial ownership of all shares held by APNG II, except to the extent of its or their respective pecuniary interests therein. Mr. More is a director of the Issuer and files separate Section 16 reports. Read SEC document |
| September 17, 2021 Filed Sep 17, 2021 20:47 UTC | Tyra Biosciences, Inc. TYRA · Entity 4680 | ConversionSeries A Preferred Stock · Derivative | 1,212,122 | $0.00 | $0.00 |
DisclosureSEC source: 0000899243-21-036429 · doc4.xml · derivative · entry 3 Alta Partners NextGen Fund II Management, LLC · CIK 0001881002 · 10% owner Alta Partners NextGen Fund II, L.P. · CIK 0001768658 · 10% owner Hudson Peter A · CIK 0001674884 · 10% owner JANNEY DANIEL · CIK 0001198325 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · See footnote Disclosed balance after: 0 Underlying: Common Stock · 3,148,365 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: On September 17, 2021, each share of Series A Preferred Stock and each share of Series B Preferred Stock converted into Common Stock of the Issuer at a ratio of 1-for-2.5974 without payment of further consideration upon closing of the initial public offering of the Issuer's common stock. The shares had no expiration date. As a result of the Issuer's initial public offering, the reporting persons are no longer 10% owners of the Issuer's common stock and are, therefore, no longer subject to Section 16 in connection with their transactions in the equity securities of the Issuer. F1 · derivative.exercise_date: On September 17, 2021, each share of Series A Preferred Stock and each share of Series B Preferred Stock converted into Common Stock of the Issuer at a ratio of 1-for-2.5974 without payment of further consideration upon closing of the initial public offering of the Issuer's common stock. The shares had no expiration date. As a result of the Issuer's initial public offering, the reporting persons are no longer 10% owners of the Issuer's common stock and are, therefore, no longer subject to Section 16 in connection with their transactions in the equity securities of the Issuer. F1 · derivative.expiration_date: On September 17, 2021, each share of Series A Preferred Stock and each share of Series B Preferred Stock converted into Common Stock of the Issuer at a ratio of 1-for-2.5974 without payment of further consideration upon closing of the initial public offering of the Issuer's common stock. The shares had no expiration date. As a result of the Issuer's initial public offering, the reporting persons are no longer 10% owners of the Issuer's common stock and are, therefore, no longer subject to Section 16 in connection with their transactions in the equity securities of the Issuer. F2 · ownership.nature: These securities are held directly by Alta Partners NextGen Fund II, L.P. (the "APNG II"). The shares directly held by APNG II are indirectly held by Alta Partners NextGen Fund II Management, LLC ("APNG II Management"), which is the general partner of APNG II. The individual managing directors of APNG II Management are Robert More, Peter Hudson and Daniel Janney. The managing directors of APNG II Management exercise shared voting and investment control with respect to the shares held by APNG II. APNG II Management, Mr. Hudson and Mr. Janney disclaim beneficial ownership of all shares held by APNG II, except to the extent of its or their respective pecuniary interests therein. Mr. More is a director of the Issuer and files separate Section 16 reports. Read SEC document |
| September 17, 2021 Filed Sep 17, 2021 20:47 UTC | Tyra Biosciences, Inc. TYRA · Entity 4680 | PurchaseCommon Stock | 156,250 | $16.00 | $2,500,000.00 |
DisclosureSEC source: 0000899243-21-036429 · doc4.xml · nonDerivative · entry 2 Alta Partners NextGen Fund II Management, LLC · CIK 0001881002 · 10% owner Alta Partners NextGen Fund II, L.P. · CIK 0001768658 · 10% owner Hudson Peter A · CIK 0001674884 · 10% owner JANNEY DANIEL · CIK 0001198325 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · See footnote Disclosed balance after: 4,080,296 F2 · ownership.nature: These securities are held directly by Alta Partners NextGen Fund II, L.P. (the "APNG II"). The shares directly held by APNG II are indirectly held by Alta Partners NextGen Fund II Management, LLC ("APNG II Management"), which is the general partner of APNG II. The individual managing directors of APNG II Management are Robert More, Peter Hudson and Daniel Janney. The managing directors of APNG II Management exercise shared voting and investment control with respect to the shares held by APNG II. APNG II Management, Mr. Hudson and Mr. Janney disclaim beneficial ownership of all shares held by APNG II, except to the extent of its or their respective pecuniary interests therein. Mr. More is a director of the Issuer and files separate Section 16 reports. Read SEC document |
| September 17, 2021 Filed Sep 17, 2021 20:47 UTC | Tyra Biosciences, Inc. TYRA · Entity 4680 | ConversionCommon Stock | 3,811,117 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000899243-21-036429 · doc4.xml · nonDerivative · entry 1 Alta Partners NextGen Fund II Management, LLC · CIK 0001881002 · 10% owner Alta Partners NextGen Fund II, L.P. · CIK 0001768658 · 10% owner Hudson Peter A · CIK 0001674884 · 10% owner JANNEY DANIEL · CIK 0001198325 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · See footnote Disclosed balance after: 3,924,046 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: On September 17, 2021, each share of Series A Preferred Stock and each share of Series B Preferred Stock converted into Common Stock of the Issuer at a ratio of 1-for-2.5974 without payment of further consideration upon closing of the initial public offering of the Issuer's common stock. The shares had no expiration date. As a result of the Issuer's initial public offering, the reporting persons are no longer 10% owners of the Issuer's common stock and are, therefore, no longer subject to Section 16 in connection with their transactions in the equity securities of the Issuer. F2 · ownership.nature: These securities are held directly by Alta Partners NextGen Fund II, L.P. (the "APNG II"). The shares directly held by APNG II are indirectly held by Alta Partners NextGen Fund II Management, LLC ("APNG II Management"), which is the general partner of APNG II. The individual managing directors of APNG II Management are Robert More, Peter Hudson and Daniel Janney. The managing directors of APNG II Management exercise shared voting and investment control with respect to the shares held by APNG II. APNG II Management, Mr. Hudson and Mr. Janney disclaim beneficial ownership of all shares held by APNG II, except to the extent of its or their respective pecuniary interests therein. Mr. More is a director of the Issuer and files separate Section 16 reports. Read SEC document |
| March 11, 2021 Filed Mar 11, 2021 19:28 UTC | Allakos Inc. ALLK · Entity 79644 | SaleCommon Stock | 972 | $125.22 | $121,713.84 |
DisclosureSEC source: 0001209191-21-019954 · doc4.xml · nonDerivative · entry 7 Hudson Peter A · CIK 0001674884 · member - potential 10% group 10b5-1 filing: Not disclosed Ownership: Indirect · By Hudson Capital LLC Disclosed balance after: 8,000 F10 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $125.02 - $125.50, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote to this Form 4. F5 · ownership.nature: These shares are owned by Hudson Capital, LLC, a limited liability company of which the Reporting Person is the managing member. The Reporting Person disclaims beneficial ownership of such shares, except to the extent of his pecuniary interest therein Read SEC document |
| March 11, 2021 Filed Mar 11, 2021 19:28 UTC | Allakos Inc. ALLK · Entity 79644 | SaleCommon Stock | 9,248 | $124.26 | $1,149,156.48 |
DisclosureSEC source: 0001209191-21-019954 · doc4.xml · nonDerivative · entry 6 Hudson Peter A · CIK 0001674884 · member - potential 10% group 10b5-1 filing: Not disclosed Ownership: Indirect · By Hudson Capital LLC Disclosed balance after: 8,972 F9 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $124.00 - $124.89, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote to this Form 4. F5 · ownership.nature: These shares are owned by Hudson Capital, LLC, a limited liability company of which the Reporting Person is the managing member. The Reporting Person disclaims beneficial ownership of such shares, except to the extent of his pecuniary interest therein Read SEC document |
| March 11, 2021 Filed Mar 11, 2021 19:28 UTC | Allakos Inc. ALLK · Entity 79644 | SaleCommon Stock | 10,027 | $123.49 | $1,238,234.23 |
DisclosureSEC source: 0001209191-21-019954 · doc4.xml · nonDerivative · entry 5 Hudson Peter A · CIK 0001674884 · member - potential 10% group 10b5-1 filing: Not disclosed Ownership: Indirect · By Hudson Capital LLC Disclosed balance after: 18,220 F8 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $123.00 - $123.99, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote to this Form 4. F5 · ownership.nature: These shares are owned by Hudson Capital, LLC, a limited liability company of which the Reporting Person is the managing member. The Reporting Person disclaims beneficial ownership of such shares, except to the extent of his pecuniary interest therein Read SEC document |
| March 10, 2021 Filed Mar 11, 2021 19:28 UTC | Allakos Inc. ALLK · Entity 79644 | SaleCommon Stock | 2,107 | $124.37 | $262,047.59 |
DisclosureSEC source: 0001209191-21-019954 · doc4.xml · nonDerivative · entry 4 Hudson Peter A · CIK 0001674884 · member - potential 10% group 10b5-1 filing: Not disclosed Ownership: Indirect · By Hudson Capital LLC Disclosed balance after: 28,247 F7 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $124.00 - $124.86, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote to this Form 4. F5 · ownership.nature: These shares are owned by Hudson Capital, LLC, a limited liability company of which the Reporting Person is the managing member. The Reporting Person disclaims beneficial ownership of such shares, except to the extent of his pecuniary interest therein Read SEC document |
| March 09, 2021 Filed Mar 11, 2021 19:28 UTC | Allakos Inc. ALLK · Entity 79644 | SaleCommon Stock | 700 | $125.58 | $87,906.00 |
DisclosureSEC source: 0001209191-21-019954 · doc4.xml · nonDerivative · entry 3 Hudson Peter A · CIK 0001674884 · member - potential 10% group 10b5-1 filing: Not disclosed Ownership: Indirect · By Hudson Capital LLC Disclosed balance after: 30,354 F6 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $125.515 - $125.80, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote to this Form 4. F5 · ownership.nature: These shares are owned by Hudson Capital, LLC, a limited liability company of which the Reporting Person is the managing member. The Reporting Person disclaims beneficial ownership of such shares, except to the extent of his pecuniary interest therein Read SEC document |
| March 09, 2021 Filed Mar 11, 2021 19:28 UTC | Allakos Inc. ALLK · Entity 79644 | SaleCommon Stock | 1,500 | $124.36 | $186,540.00 |
DisclosureSEC source: 0001209191-21-019954 · doc4.xml · nonDerivative · entry 2 Hudson Peter A · CIK 0001674884 · member - potential 10% group 10b5-1 filing: Not disclosed Ownership: Indirect · By Hudson Capital LLC Disclosed balance after: 31,054 F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $124.10 - $125.04, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote to this Form 4. F4 · balance_after: Shares held prior to the reported transaction consisted of an aggregate of 32,554 shares received in pro rata distributions from APNG I subsequent to the Reporting Person's most recent Section 16 report, which distribution was not required to be reported pursuant to Section 16. F5 · ownership.nature: These shares are owned by Hudson Capital, LLC, a limited liability company of which the Reporting Person is the managing member. The Reporting Person disclaims beneficial ownership of such shares, except to the extent of his pecuniary interest therein Read SEC document |
| August 24, 2020 Filed Aug 25, 2020 14:48 UTC | TIVITY HEALTH, INC. TVTY · Entity 125776 | GrantCommon Stock | 1,821 | $0.00 | $0.00 |
DisclosureSEC source: 0001567619-20-015939 · doc1.xml · nonDerivative · entry 1 Hudson Peter A · CIK 0001674884 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 76,211 F1 · shares: Reflects restricted stock units that vest in full on August 24, 2021. Read SEC document |
| May 21, 2020 Filed May 26, 2020 13:35 UTC | TIVITY HEALTH, INC. TVTY · Entity 125776 | GrantCommon Stock | 10,827 | $0.00 | $0.00 |
DisclosureSEC source: 0001567619-20-011132 · doc1.xml · nonDerivative · entry 1 Hudson Peter A · CIK 0001674884 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 74,390 F1 · shares: Reflects restricted stock units that vest on the earlier of (i) the first anniversary of the Grant Date (such Grant Date being 5/21/2020), or (ii) the first annual meeting of the stockholders of Tivity Health that occurs after the Grant Date. Read SEC document |
| May 18, 2020 Filed May 20, 2020 18:07 UTC | Allakos Inc. ALLK · Entity 79644 | SaleCommon Stock | 6,989 | $72.33 | $505,514.37 |
DisclosureSEC source: 0001209191-20-031000 · doc4.xml · nonDerivative · entry 2 Hudson Peter A · CIK 0001674884 · member - potential 10% group 10b5-1 filing: Not disclosed Ownership: Indirect · By Hudson Capital LLC Disclosed balance after: 0 F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $71.83 - $72.74, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote to this Form 4. F2 · ownership.nature: These shares are owned by Hudson Capital, LLC, a limited liability company of which the Reporting Person is the managing member. The Reporting Person disclaims beneficial ownership of such shares, except to the extent of his pecuniary interest therein Read SEC document |
| May 18, 2020 Filed May 20, 2020 18:07 UTC | Allakos Inc. ALLK · Entity 79644 | SaleCommon Stock | 4,549 | $71.13 | $323,570.37 |
DisclosureSEC source: 0001209191-20-031000 · doc4.xml · nonDerivative · entry 1 Hudson Peter A · CIK 0001674884 · member - potential 10% group 10b5-1 filing: Not disclosed Ownership: Indirect · By Hudson Capital LLC Disclosed balance after: 6,989 F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $70.72 - $71.67, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote to this Form 4. F2 · ownership.nature: These shares are owned by Hudson Capital, LLC, a limited liability company of which the Reporting Person is the managing member. The Reporting Person disclaims beneficial ownership of such shares, except to the extent of his pecuniary interest therein Read SEC document |
| May 11, 2020 Filed May 13, 2020 16:59 UTC | TIVITY HEALTH, INC. TVTY · Entity 125776 | GrantCommon Stock | 3,202 | $0.00 | $0.00 |
DisclosureSEC source: 0001567619-20-009827 · doc1.xml · nonDerivative · entry 1 Hudson Peter A · CIK 0001674884 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 63,563 F1 · shares: Reflects restricted stock units that vest in full on May 11, 2021. Read SEC document |
| March 13, 2020 Filed Mar 17, 2020 08:43 UTC | TIVITY HEALTH, INC. TVTY · Entity 125776 | PurchaseCommon Stock | 40,000 | $5.10 | $204,000.00 |
DisclosureSEC source: 0001567619-20-006516 · doc1.xml · nonDerivative · entry 1 Hudson Peter A · CIK 0001674884 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 60,361 F1 · price: This transaction was executed in multiple trades at prices ranging from $5.00 to $5.15, inclusive. The price reported above reflects the weighted-average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transactions were effected. Read SEC document |
| January 22, 2020 Filed Jan 24, 2020 18:24 UTC | Allakos Inc. ALLK · Entity 79644 | OtherCommon Stock | 6,837 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-20-004922 · doc4.xml · nonDerivative · entry 7 Alta Partners NextGen Fund I Management, LLC · CIK 0001736001 · 10% owner Alta Partners Management VIII, LLC · CIK 0001399894 · 10% owner Alta Partners NextGen Fund I, L.P. · CIK 0001698110 · 10% owner CHAMPSI FARAH · CIK 0001198321 · 10% owner Hudson Peter A · CIK 0001674884 · 10% owner MORE ROBERT J · CIK 0001207792 · 10% owner NOHRA GUY P · CIK 0001198330 · 10% owner Alta Partners VIII, L.P. · CIK 0001399763 · 10% owner JANNEY DANIEL · CIK 0001198325 · Director · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,837 F9 · kind: Represents the acquisition of the shares of Common Stock of the Issuer by Guy P. Nohra in connection with the pro-rata distribution described in footnote (1) herein. F9 · ownership.direct: Represents the acquisition of the shares of Common Stock of the Issuer by Guy P. Nohra in connection with the pro-rata distribution described in footnote (1) herein. Read SEC document |
| January 22, 2020 Filed Jan 24, 2020 18:24 UTC | Allakos Inc. ALLK · Entity 79644 | OtherCommon Stock | 11,539 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-20-004922 · doc4.xml · nonDerivative · entry 6 Alta Partners NextGen Fund I Management, LLC · CIK 0001736001 · 10% owner Alta Partners Management VIII, LLC · CIK 0001399894 · 10% owner Alta Partners NextGen Fund I, L.P. · CIK 0001698110 · 10% owner CHAMPSI FARAH · CIK 0001198321 · 10% owner Hudson Peter A · CIK 0001674884 · 10% owner MORE ROBERT J · CIK 0001207792 · 10% owner NOHRA GUY P · CIK 0001198330 · 10% owner Alta Partners VIII, L.P. · CIK 0001399763 · 10% owner JANNEY DANIEL · CIK 0001198325 · Director · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · By Alta Bioequities, L.P. Disclosed balance after: 11,539 F8 · kind: Represents the acquisition of the shares of Common Stock of the Issuer by Alta Bioequities, L.P. in connection with the pro-rata distribution described in footnote (5) herein. Alta Bioequities Management, LLC is the general partner of Alta Bioequities, L.P. and may be deemed to have sole voting and investment power over the shares beneficially owned by Alta Bioequities, L.P. Daniel Janney is the Managing Director of Alta Bioequities Management, LLC. The reporting person disclaims beneficial ownership of such shares except to the extent of his pecuniary interest therein. F8 · ownership.nature: Represents the acquisition of the shares of Common Stock of the Issuer by Alta Bioequities, L.P. in connection with the pro-rata distribution described in footnote (5) herein. Alta Bioequities Management, LLC is the general partner of Alta Bioequities, L.P. and may be deemed to have sole voting and investment power over the shares beneficially owned by Alta Bioequities, L.P. Daniel Janney is the Managing Director of Alta Bioequities Management, LLC. The reporting person disclaims beneficial ownership of such shares except to the extent of his pecuniary interest therein. Read SEC document |
| January 22, 2020 Filed Jan 24, 2020 18:24 UTC | Allakos Inc. ALLK · Entity 79644 | OtherCommon Stock | 11,538 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-20-004922 · doc4.xml · nonDerivative · entry 5 Alta Partners NextGen Fund I Management, LLC · CIK 0001736001 · 10% owner Alta Partners Management VIII, LLC · CIK 0001399894 · 10% owner Alta Partners NextGen Fund I, L.P. · CIK 0001698110 · 10% owner CHAMPSI FARAH · CIK 0001198321 · 10% owner Hudson Peter A · CIK 0001674884 · 10% owner MORE ROBERT J · CIK 0001207792 · 10% owner NOHRA GUY P · CIK 0001198330 · 10% owner Alta Partners VIII, L.P. · CIK 0001399763 · 10% owner JANNEY DANIEL · CIK 0001198325 · Director · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · By Hudson Capital LLC Disclosed balance after: 11,538 F7 · kind: Represents the acquisition of the shares of Common Stock of the Issuer by Hudson Capital, LLC, a limited liability company of which Peter A. Hudson is the managing member, in connection with the pro-rata distribution described in footnote (5) herein. Mr. Hudson disclaims beneficial ownership of such shares, except to the extent of his pecuniary interest therein. F7 · ownership.nature: Represents the acquisition of the shares of Common Stock of the Issuer by Hudson Capital, LLC, a limited liability company of which Peter A. Hudson is the managing member, in connection with the pro-rata distribution described in footnote (5) herein. Mr. Hudson disclaims beneficial ownership of such shares, except to the extent of his pecuniary interest therein. Read SEC document |
| January 22, 2020 Filed Jan 24, 2020 18:24 UTC | Allakos Inc. ALLK · Entity 79644 | OtherCommon Stock | 11,538 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-20-004922 · doc4.xml · nonDerivative · entry 4 Alta Partners NextGen Fund I Management, LLC · CIK 0001736001 · 10% owner Alta Partners Management VIII, LLC · CIK 0001399894 · 10% owner Alta Partners NextGen Fund I, L.P. · CIK 0001698110 · 10% owner CHAMPSI FARAH · CIK 0001198321 · 10% owner Hudson Peter A · CIK 0001674884 · 10% owner MORE ROBERT J · CIK 0001207792 · 10% owner NOHRA GUY P · CIK 0001198330 · 10% owner Alta Partners VIII, L.P. · CIK 0001399763 · 10% owner JANNEY DANIEL · CIK 0001198325 · Director · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,538 F6 · kind: Represents the acquisition of the shares of Common Stock of the Issuer by Robert J. More in connection with the pro-rata distribution described in footnote (5) herein. F6 · ownership.direct: Represents the acquisition of the shares of Common Stock of the Issuer by Robert J. More in connection with the pro-rata distribution described in footnote (5) herein. Read SEC document |
| January 22, 2020 Filed Jan 24, 2020 18:24 UTC | Allakos Inc. ALLK · Entity 79644 | OtherCommon Stock | 34,615 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-20-004922 · doc4.xml · nonDerivative · entry 3 Alta Partners NextGen Fund I Management, LLC · CIK 0001736001 · 10% owner Alta Partners Management VIII, LLC · CIK 0001399894 · 10% owner Alta Partners NextGen Fund I, L.P. · CIK 0001698110 · 10% owner CHAMPSI FARAH · CIK 0001198321 · 10% owner Hudson Peter A · CIK 0001674884 · 10% owner MORE ROBERT J · CIK 0001207792 · 10% owner NOHRA GUY P · CIK 0001198330 · 10% owner Alta Partners VIII, L.P. · CIK 0001399763 · 10% owner JANNEY DANIEL · CIK 0001198325 · Director · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · By APNG I Management Disclosed balance after: 0 F5 · kind: Represents a pro-rata in-kind distribution of Common Stock of the Issuer by APNG I Management, without consideration, to its members. Read SEC document |
| January 22, 2020 Filed Jan 24, 2020 18:24 UTC | Allakos Inc. ALLK · Entity 79644 | OtherCommon Stock | 34,615 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-20-004922 · doc4.xml · nonDerivative · entry 2 Alta Partners NextGen Fund I Management, LLC · CIK 0001736001 · 10% owner Alta Partners Management VIII, LLC · CIK 0001399894 · 10% owner Alta Partners NextGen Fund I, L.P. · CIK 0001698110 · 10% owner CHAMPSI FARAH · CIK 0001198321 · 10% owner Hudson Peter A · CIK 0001674884 · 10% owner MORE ROBERT J · CIK 0001207792 · 10% owner NOHRA GUY P · CIK 0001198330 · 10% owner Alta Partners VIII, L.P. · CIK 0001399763 · 10% owner JANNEY DANIEL · CIK 0001198325 · Director · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · By APNG I Management Disclosed balance after: 34,615 F1 · kind: Represents a pro-rata in-kind distribution of Common Stock of the Issuer by Alta Partners NextGen Fund I L.P. ("APNG I"), without consideration, to its general partner and limited partners. Read SEC document |
| January 22, 2020 Filed Jan 24, 2020 18:24 UTC | Allakos Inc. ALLK · Entity 79644 | OtherCommon Stock | 1,000,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-20-004922 · doc4.xml · nonDerivative · entry 1 Alta Partners NextGen Fund I Management, LLC · CIK 0001736001 · 10% owner Alta Partners Management VIII, LLC · CIK 0001399894 · 10% owner Alta Partners NextGen Fund I, L.P. · CIK 0001698110 · 10% owner CHAMPSI FARAH · CIK 0001198321 · 10% owner Hudson Peter A · CIK 0001674884 · 10% owner MORE ROBERT J · CIK 0001207792 · 10% owner NOHRA GUY P · CIK 0001198330 · 10% owner Alta Partners VIII, L.P. · CIK 0001399763 · 10% owner JANNEY DANIEL · CIK 0001198325 · Director · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnote Disclosed balance after: 10,519,200 F1 · kind: Represents a pro-rata in-kind distribution of Common Stock of the Issuer by Alta Partners NextGen Fund I L.P. ("APNG I"), without consideration, to its general partner and limited partners. F2 · ownership.nature: Consists of 2,557,377 shares held of record by APNG I and 7,961,823 shares held of record by Alta Partners VIII, L.P. ("Alta VIII"). F3 · ownership.nature: The shares directly held by Alta VIII are indirectly held by Alta Partners Management VIII, LLC ("Alta Management VIII"), which is the general partner of Alta VIII. The individual managing directors of Alta Management VIII are Farah Champsi, Guy Nohra and Daniel Janney. The managing directors of Alta Management VIII exercise sole voting and investment control with respect to the shares held by Alta VIII. The individual managing directors of Alta Management VIII disclaim beneficial ownership of all shares held by Alta VIII, except to the extent of their respective pecuniary interests therein. F4 · ownership.nature: The shares directly held by APNG I are indirectly held by Alta Partners NextGen Fund I Management, LLC ("APNG I Management"), which is the general partner of APNG I. The individual managing directors of APNG I Management are Robert More, Peter Hudson and Daniel Janney. The managing directors of APNG I Management exercise sole voting and investment control with respect to the shares held by APNG I. The individual managing directors of APNG I Management disclaim beneficial ownership of all shares held by APNG I, except to the extent of their respective pecuniary interests therein. Read SEC document |
| May 23, 2019 Filed May 28, 2019 14:59 UTC | TIVITY HEALTH, INC. TVTY · Entity 125776 | GrantCommon Stock | 6,098 | $0.00 | $0.00 |
DisclosureSEC source: 0001567619-19-012193 · doc1.xml · nonDerivative · entry 1 Hudson Peter A · CIK 0001674884 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,361 F1 · shares: Reflects restricted stock units that vest on the earlier of (i) the first anniversary of the Grant Date (such Grant Date being 5/23/2019), or (ii) the first annual meeting of the stockholders of Tivity Health that occurs after the Grant Date. Read SEC document |
| July 23, 2018 Filed Jul 23, 2018 17:01 UTC | Allakos Inc. ALLK · Entity 79644 | ConversionSeries B Preferred Stock · Derivative | 1,239,007 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-18-043627 · doc4.xml · derivative · entry 4 Alta Partners VIII, L.P. · CIK 0001399763 · 10% owner Alta Partners Management VIII, LLC · CIK 0001399894 · 10% owner Alta Partners NextGen Fund I Management, LLC · CIK 0001736001 · 10% owner Alta Partners NextGen Fund I, L.P. · CIK 0001698110 · 10% owner CHAMPSI FARAH · CIK 0001198321 · 10% owner Hudson Peter A · CIK 0001674884 · 10% owner MORE ROBERT J · CIK 0001207792 · 10% owner NOHRA GUY P · CIK 0001198330 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · See footnote Disclosed balance after: 0 Underlying: Common Stock · 1,239,007 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: The Series B Preferred Stock automatically converted into Common Stock on a one-for-one basis immediately prior to the closing of the Issuer's initial public offering and had no expiration date. F2 · derivative.exercise_date: The Series B Preferred Stock automatically converted into Common Stock on a one-for-one basis immediately prior to the closing of the Issuer's initial public offering and had no expiration date. F2 · derivative.expiration_date: The Series B Preferred Stock automatically converted into Common Stock on a one-for-one basis immediately prior to the closing of the Issuer's initial public offering and had no expiration date. F4 · ownership.nature: The shares directly held by Alta VIII are indirectly held by Alta Partners Management VIII, LLC ("Alta Management VIII"), which is the general partner of Alta VIII. The individual managing directors of Alta Management VIII are Farah Champsi, Guy Nohra and Daniel Janney. The managing directors of Alta Management VIII exercise sole voting and investment control with respect to the shares held by Alta VIII. The individual managing directors of Alta Management VIII disclaim beneficial ownership of all shares held by Alta VIII, except to the extent of their pecuniary interests therein. F5 · ownership.nature: The shares directly held by APNG I are indirectly held by Alta Partners NextGen Fund I Management, LLC ("APNG I Management"), which is the general partner of APNG I. The individual managing directors of APNG I Management are Robert More, Peter Hudson and Daniel Janney. The managing directors of APNG I Management exercise sole voting and investment control with respect to the shares held by APNG I. The individual managing directors of APNG I Management disclaim beneficial ownership of all shares held by APNG I, except to the extent of their pecuniary interests therein. F8 · ownership.nature: APNG I owns 504,547 shares of Series B Preferred Stock. Alta VIII owns 734,460 shares of Series B Preferred Stock. Read SEC document |
| July 23, 2018 Filed Jul 23, 2018 17:01 UTC | Allakos Inc. ALLK · Entity 79644 | ConversionSeries A Preferred Stock · Derivative | 10,030,193 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-18-043627 · doc4.xml · derivative · entry 3 Alta Partners VIII, L.P. · CIK 0001399763 · 10% owner Alta Partners Management VIII, LLC · CIK 0001399894 · 10% owner Alta Partners NextGen Fund I Management, LLC · CIK 0001736001 · 10% owner Alta Partners NextGen Fund I, L.P. · CIK 0001698110 · 10% owner CHAMPSI FARAH · CIK 0001198321 · 10% owner Hudson Peter A · CIK 0001674884 · 10% owner MORE ROBERT J · CIK 0001207792 · 10% owner NOHRA GUY P · CIK 0001198330 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · See footnote Disclosed balance after: 0 Underlying: Common Stock · 10,030,193 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: The Series A Preferred Stock automatically converted into Common Stock on a one-for-one basis immediately prior to the closing of the Issuer's initial public offering and had no expiration date. F1 · derivative.exercise_date: The Series A Preferred Stock automatically converted into Common Stock on a one-for-one basis immediately prior to the closing of the Issuer's initial public offering and had no expiration date. F1 · derivative.expiration_date: The Series A Preferred Stock automatically converted into Common Stock on a one-for-one basis immediately prior to the closing of the Issuer's initial public offering and had no expiration date. F4 · ownership.nature: The shares directly held by Alta VIII are indirectly held by Alta Partners Management VIII, LLC ("Alta Management VIII"), which is the general partner of Alta VIII. The individual managing directors of Alta Management VIII are Farah Champsi, Guy Nohra and Daniel Janney. The managing directors of Alta Management VIII exercise sole voting and investment control with respect to the shares held by Alta VIII. The individual managing directors of Alta Management VIII disclaim beneficial ownership of all shares held by Alta VIII, except to the extent of their pecuniary interests therein. F5 · ownership.nature: The shares directly held by APNG I are indirectly held by Alta Partners NextGen Fund I Management, LLC ("APNG I Management"), which is the general partner of APNG I. The individual managing directors of APNG I Management are Robert More, Peter Hudson and Daniel Janney. The managing directors of APNG I Management exercise sole voting and investment control with respect to the shares held by APNG I. The individual managing directors of APNG I Management disclaim beneficial ownership of all shares held by APNG I, except to the extent of their pecuniary interests therein. F7 · ownership.nature: APNG I owns 2,941,718 shares of Series A Preferred Stock. Alta VIII owns 7,088,475 shares of Series A Preferred Stock. Read SEC document |
| July 23, 2018 Filed Jul 23, 2018 17:01 UTC | Allakos Inc. ALLK · Entity 79644 | PurchaseCommon Stock | 250,000 | $18.00 | $4,500,000.00 |
DisclosureSEC source: 0001209191-18-043627 · doc4.xml · nonDerivative · entry 2 Alta Partners VIII, L.P. · CIK 0001399763 · 10% owner Alta Partners Management VIII, LLC · CIK 0001399894 · 10% owner Alta Partners NextGen Fund I Management, LLC · CIK 0001736001 · 10% owner Alta Partners NextGen Fund I, L.P. · CIK 0001698110 · 10% owner CHAMPSI FARAH · CIK 0001198321 · 10% owner Hudson Peter A · CIK 0001674884 · 10% owner MORE ROBERT J · CIK 0001207792 · 10% owner NOHRA GUY P · CIK 0001198330 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · See footnote Disclosed balance after: 11,519,200 F4 · ownership.nature: The shares directly held by Alta VIII are indirectly held by Alta Partners Management VIII, LLC ("Alta Management VIII"), which is the general partner of Alta VIII. The individual managing directors of Alta Management VIII are Farah Champsi, Guy Nohra and Daniel Janney. The managing directors of Alta Management VIII exercise sole voting and investment control with respect to the shares held by Alta VIII. The individual managing directors of Alta Management VIII disclaim beneficial ownership of all shares held by Alta VIII, except to the extent of their pecuniary interests therein. F5 · ownership.nature: The shares directly held by APNG I are indirectly held by Alta Partners NextGen Fund I Management, LLC ("APNG I Management"), which is the general partner of APNG I. The individual managing directors of APNG I Management are Robert More, Peter Hudson and Daniel Janney. The managing directors of APNG I Management exercise sole voting and investment control with respect to the shares held by APNG I. The individual managing directors of APNG I Management disclaim beneficial ownership of all shares held by APNG I, except to the extent of their pecuniary interests therein. F6 · ownership.nature: Consists of 3,557,377 shares held of record by APNG I and 7,961,823 shares held of record by Alta VIII. Read SEC document |
| July 23, 2018 Filed Jul 23, 2018 17:01 UTC | Allakos Inc. ALLK · Entity 79644 | ConversionCommon Stock | 11,269,200 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001209191-18-043627 · doc4.xml · nonDerivative · entry 1 Alta Partners VIII, L.P. · CIK 0001399763 · 10% owner Alta Partners Management VIII, LLC · CIK 0001399894 · 10% owner Alta Partners NextGen Fund I Management, LLC · CIK 0001736001 · 10% owner Alta Partners NextGen Fund I, L.P. · CIK 0001698110 · 10% owner CHAMPSI FARAH · CIK 0001198321 · 10% owner Hudson Peter A · CIK 0001674884 · 10% owner MORE ROBERT J · CIK 0001207792 · 10% owner NOHRA GUY P · CIK 0001198330 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · See footnote Disclosed balance after: 11,269,200 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: The Series A Preferred Stock automatically converted into Common Stock on a one-for-one basis immediately prior to the closing of the Issuer's initial public offering and had no expiration date. F2 · price: The Series B Preferred Stock automatically converted into Common Stock on a one-for-one basis immediately prior to the closing of the Issuer's initial public offering and had no expiration date. F3 · ownership.nature: Consists of 3,446,265 shares held of record by Alta Partners NextGen Fund I, L.P. ("APNG I") and 7,822,935 shares held of record by Alta Partners VIII, L.P. ("Alta VIII"). F4 · ownership.nature: The shares directly held by Alta VIII are indirectly held by Alta Partners Management VIII, LLC ("Alta Management VIII"), which is the general partner of Alta VIII. The individual managing directors of Alta Management VIII are Farah Champsi, Guy Nohra and Daniel Janney. The managing directors of Alta Management VIII exercise sole voting and investment control with respect to the shares held by Alta VIII. The individual managing directors of Alta Management VIII disclaim beneficial ownership of all shares held by Alta VIII, except to the extent of their pecuniary interests therein. F5 · ownership.nature: The shares directly held by APNG I are indirectly held by Alta Partners NextGen Fund I Management, LLC ("APNG I Management"), which is the general partner of APNG I. The individual managing directors of APNG I Management are Robert More, Peter Hudson and Daniel Janney. The managing directors of APNG I Management exercise sole voting and investment control with respect to the shares held by APNG I. The individual managing directors of APNG I Management disclaim beneficial ownership of all shares held by APNG I, except to the extent of their pecuniary interests therein. Read SEC document |
| May 24, 2018 Filed May 25, 2018 12:57 UTC | TIVITY HEALTH, INC. TVTY · Entity 125776 | GrantCommon Stock | 2,876 | $0.00 | $0.00 |
DisclosureSEC source: 0001140361-18-025688 · doc1.xml · nonDerivative · entry 1 Hudson Peter A · CIK 0001674884 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,263 F1 · shares: Reflects restricted stock units that vest on the earlier of (i) the first anniversary of the Grant Date (such Grant Date being 5/24/2018), or (ii) the first annual meeting of the stockholders of Tivity Health that occurs after the Grant Date. Read SEC document |
| May 25, 2017 Filed May 30, 2017 10:40 UTC | TIVITY HEALTH, INC. TVTY · Entity 125776 | GrantCommon Stock | 3,012 | $0.00 | $0.00 |
DisclosureSEC source: 0001140361-17-022639 · doc1.xml · nonDerivative · entry 1 Hudson Peter A · CIK 0001674884 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,387 F1 · shares: Reflects restricted stock units that vest on 5/25/2018. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.